Oneview Healthcare Launches Epic-Certified Bedside Hub with US Expansion Plans

Oneview Healthcare reported a €2.9 million cash outflow in Q2 2026 while launching its Epic-certified Bedside Hub, targeting multiple new customers and advancing engagement with a major US health system.

  • Q2 cash balance declined to €7.2 million
  • A$19 million placement partly settled, second tranche pending
  • Bedside Hub launch certified by Epic with strong market interest
  • Engagement progressing with large US health system for H2 2026 projects
  • Ovie AI Care Assistant pilot deployments underway
An image related to Oneview Healthcare PLC
Image © middle. Logo © respective owner.

Quarterly Cash Flow and Capital Raise Status

Oneview Healthcare PLC (ASX:ONE) ended June 2026 with a cash balance of €7.2 million, down from €10.3 million three months earlier, reflecting a net operating cash outflow of €2.9 million. The company’s cash position was bolstered earlier in the year by a two-tranche institutional placement raising A$19 million, of which the first tranche of A$12 million has settled. The second tranche, worth A$7 million, remains subject to shareholder approval expected at the September AGM. If completed, this would have lifted the pro forma cash balance at quarter-end to approximately €11.4 million.

Bedside Hub Launch and Market Traction

May 2026 saw Oneview launch its Bedside Hub, a new revenue channel designed to host Epic MyChart Bedside TV on healthcare-grade hardware with cloud-based management. The product’s certification by Epic has sparked significant interest from health systems evaluating Epic TV deployments, with the company targeting three to four new Bedside Hub customers in the second half of 2026. Oneview will showcase the solution at the Epic User Group Meeting in Wisconsin in August, an important platform for engaging potential customers and partners within the Epic ecosystem.

Progress with Major US Health System

Oneview continues to advance discussions with one of the United States’ ten largest health systems following the inclusion of its products under an amendment to Baxter’s National Care Communication Agreement with the health system’s group purchasing organisation. Projects with this health system, which encompasses over 85 hospitals and 15,000 beds, are expected to commence in the second half of 2026, representing a significant commercial opportunity and potential expansion pathway.

Product Development and AI Care Assistant Pilots

The company is nearing completion of its redesigned patient user interface, with improvements to service requests, patient schedules, and surveys focusing on usability and accessibility. Parallel to this, Oneview is preparing pilot deployments for Ovie, its AI-powered digital Care Assistant, with pilot sites and project charters in place. These pilots aim to validate workflows and operational impact ahead of broader commercialisation. Additionally, a re-architecture of the data analytics platform was completed, improving data update frequency and insights access.

Cost Management and Outlook

Oneview reported a lower cash outflow compared to the previous year’s corresponding quarter, attributing the improvement to tighter cost control and efficiency initiatives. CEO James Fitter expressed confidence in delivering a strong second half of 2026, supported by the robust pipeline for Bedside Hub and ongoing engagements with major customers. The company plans to provide a detailed update on its operational and financial performance with the half-year results scheduled for 27 August 2026.

Bottom Line?

Oneview’s Epic-certified Bedside Hub and expanding US health system projects set the stage for growth, but the pending approval of its capital raise tranche remains a key variable.

Questions in the middle?

  • Will shareholder approval for the second tranche of the placement be secured at the September AGM?
  • How quickly can the Bedside Hub convert its growing pipeline into paying customers?
  • What operational impact will the Ovie AI Care Assistant pilots demonstrate ahead of commercial rollout?